His scientific interests lie mostly in Cancer, Prostate cancer, Prostate-specific antigen, Prostate and Internal medicine. His biological study deals with issues like Bioinformatics, which deal with fields such as Computational biology, Biomarker discovery, Proteomics and Data science. His Prostate cancer research is multidisciplinary, incorporating elements of Gynecology, Hyperplasia and Urology.
His study in Prostate-specific antigen is interdisciplinary in nature, drawing from both Survival analysis and Antigen. Daniel W. Chan has researched Prostate in several fields, including Case-control study and Pathology. His Internal medicine research includes themes of Gastroenterology, Endocrinology, Immunoassay and Oncology.
His primary scientific interests are in Internal medicine, Prostate cancer, Cancer, Prostate-specific antigen and Oncology. His study looks at the relationship between Internal medicine and fields such as Immunoassay, as well as how they intersect with chemical problems. The various areas that Daniel W. Chan examines in his Prostate cancer study include Biopsy, Prostate, Antigen and Gynecology.
His Prostate study combines topics in areas such as Stage and Prospective cohort study. His Cancer research includes elements of Cancer research, Proteomics and Bioinformatics. His work carried out in the field of Prostate-specific antigen brings together such families of science as Pathology and Urology.
Daniel W. Chan focuses on Proteomics, Computational biology, Internal medicine, Cancer and Proteome. His biological study spans a wide range of topics, including Glycosylation, Cancer research, Proteogenomics and Mass spectrometry. His work deals with themes such as Quantitative proteomics, Gene, Bioinformatics and Biomarker discovery, which intersect with Computational biology.
His Internal medicine research is multidisciplinary, relying on both Gynecology and Oncology. His Oncology research is multidisciplinary, incorporating perspectives in Urine and Prostate cancer. His Prostate cancer study incorporates themes from Biopsy, Urinary system and Urology.
Daniel W. Chan mostly deals with Proteomics, Computational biology, Proteome, Proteogenomics and Mass spectrometry. His research in Proteomics intersects with topics in Peptide and Glycan. His studies deal with areas such as Cancer research, Ovarian cancer, Serous fluid and DNA repair as well as Proteogenomics.
Daniel W. Chan works mostly in the field of Cancer research, limiting it down to topics relating to Aleuria aurantia and, in certain cases, Prostate. His Cancer study frequently draws connections to adjacent fields such as Urology. The study incorporates disciplines such as Gynecology and Antigen in addition to Prostate cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Natural history of progression after PSA elevation following radical prostatectomy.
Charles R. Pound;Alan W. Partin;Mario A. Eisenberger;Daniel W. Chan.
The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer
Alan W. Partin;John Yoo;H. Ballentine Carter;Jay D. Pearson.
The Journal of Urology (1993)
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.
H. Ballentine Carter;Jay D. Pearson;E. Jeffrey Metter;Larry J. Brant;Larry J. Brant.
Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer
Jinong Li;Zhen Zhang;Jason Rosenzweig;Young Y. Wang.
Clinical Chemistry (2002)
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Zhen Zhang;Robert C. Bast;Yinhua Yu;Jinong Li.
Cancer Research (2004)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang;Jing Wang;Xiaojing Wang;Jing Zhu.
Immunosensors--principles and applications to clinical chemistry.
Peter B. Luppa;Lori J. Sokoll;Daniel W. Chan.
Clinica Chimica Acta (2001)
Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia
Alan W. Partin;H. Ballentine Carter;Daniel W. Chan;Jonathan I. Epstein.
The Journal of Urology (1990)
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
Gilbert S. Omenn;David J. States;Marcin Adamski;Thomas W. Blackwell.
Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy
Joseph E. Oesterling;Daniel W. Chan;Jonathan I. Epstein;Allyn W. Kimball.
The Journal of Urology (1988)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: